PHLPP2 and carcinoma: GEPIA was used to detect PHLPP2 mRNA levels in different carcinomas.25 We first determined that PHLPP2 was significantly downregulated in kidney renal clear cell carcinoma and thyroid carcinoma tissues (Fig 1a).